Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-15-004135
Filing Date
2015-05-22
Accepted
2015-05-22 17:08:35
Documents
1
Period of Report
2015-05-07

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4050715dave_actinium.html 4  
1 OWNERSHIP DOCUMENT f4050715dave_actinium.xml 4 17297
  Complete submission text file 0001213900-15-004135.txt   18726
Mailing Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-300-2131
Actinium Pharmaceuticals, Inc. (Issuer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4 WATER STREET EDISON NJ 08820
Business Address
DAVE KAUSHIK J (Reporting) CIK: 0001522751 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36374 | Film No.: 15887422